CRWD analyst scorecard · CrowdStrike
202 rating actions on CRWD in the last 12 months. Of 60 price targets that resolved, 38 were reached while they stood, 22 were replaced by the same firm first, and 0 fell short at their deadline. Ratings: 81% Buy-type, 19% Hold-type, 0% Sell-type. Consensus target $247, 4% below the last close.
Checked through 2026-10-29 · last close $258.23 (2026-10-29). Rebuilt every morning.
Targets reached while they stood
63.3% 38 of 60
Replaced before the deadline
36.7%
Short at the deadline
0.0%
Ratings vs XLK
18 of 26
Buy / Hold / Sell, 12 mo
81 / 19 / 0%
Consensus target
$247 -4.3%
What the Holds say: 14 Hold-type ratings on CRWD in the last 12 months carried a median target +4% from the price on the day; 43% sat below it.
The 9 upgrades on CRWD came after an average +0.3% move in the 30 days before them.
Firm by firm
| Firm | Latest rating | Date | Latest target | Targets reached | Replaced early | Resolved | Ratings vs sector |
|---|---|---|---|---|---|---|---|
| Mizuho | Outperform | 2026-10-22 | $275 | 1 | 1 | 2 | — |
| Wells Fargo | Overweight | 2026-10-13 | $300 | 1 | 1 | 2 | 1 of 1 |
| TD Cowen | Buy | 2026-10-02 | $280 | 2 | 1 | 3 | — |
| Benchmark | Buy | 2026-08-27 | $250 | 2 | 1 | 3 | — |
| Jefferies | Buy | 2026-08-27 | $240 | 1 | 1 | 2 | 1 of 1 |
| KeyBanc | Overweight | 2026-10-16 | $265 | 2 | 1 | 3 | 1 of 1 |
| Truist Securities | Buy | 2026-09-01 | $300 | 0 | 1 | 1 | 1 of 1 |
| Barclays | Overweight | 2026-08-18 | $235 | 1 | 1 | 2 | 1 of 1 |
| Stifel | Buy | 2026-07-17 | $230 | 1 | 1 | 2 | 1 of 1 |
| Scotiabank | Sector Outperform | 2026-09-04 | $265 | 2 | 1 | 3 | 1 of 1 |
| BTIG | Buy | 2026-10-14 | $312 | 2 | 1 | 3 | 0 of 1 |
| Cantor Fitzgerald | Overweight | 2026-08-27 | $250 | 2 | 0 | 2 | 1 of 1 |
| Needham | Buy | 2026-10-09 | $310 | 2 | 1 | 3 | 1 of 1 |
| Morgan Stanley | Overweight | 2026-09-21 | $254 | 1 | 2 | 3 | — |
| Rosenblatt | Buy | 2026-09-04 | $250 | 3 | 0 | 3 | 1 of 1 |
| UBS | Buy | 2026-08-27 | $250 | 1 | 1 | 2 | 0 of 1 |
| RBC Capital | Outperform | 2026-09-03 | $260 | 2 | 1 | 3 | 1 of 1 |
| Citigroup | Buy | 2026-10-15 | $295 | 1 | 1 | 2 | 1 of 1 |
| DA Davidson | Buy | 2026-09-02 | $245 | 2 | 0 | 2 | 0 of 1 |
| BMO Capital | Outperform | 2026-10-08 | $295 | — | — | 0 | 1 of 1 |
| Citizens | Market Outperform | 2026-08-27 | $230 | — | — | 0 | — |
| JPMorgan | Overweight | 2026-08-20 | $235 | 1 | 0 | 1 | 1 of 1 |
| Wedbush | Outperform | 2026-06-04 | — | — | — | 0 | 0 of 1 |
| Baird | Neutral | 2026-09-03 | $235 | 1 | 2 | 3 | — |
| Piper Sandler | Overweight | 2026-08-27 | $240 | 1 | 0 | 1 | — |
| Argus Research | Buy | 2026-08-28 | $425 | 0 | 1 | 1 | — |
| BNP Paribas | Neutral | 2026-06-04 | $520 | — | — | 0 | — |
| Roth Capital | Buy | 2026-09-04 | $220 | — | — | 0 | 0 of 1 |
| Raymond James | Outperform | 2026-09-03 | $250 | 1 | 0 | 1 | 0 of 1 |
| Loop Capital | Buy | 2026-07-28 | $230 | 1 | 0 | 1 | — |
| Wolfe Research | Outperform | 2026-03-30 | — | — | — | 0 | — |
| Bernstein | Market Perform | 2026-09-17 | $132 | 0 | 2 | 2 | — |
| Susquehanna | Positive | 2026-06-04 | — | — | — | 0 | 1 of 1 |
| Oppenheimer | Outperform | 2026-02-24 | — | — | — | 0 | 1 of 1 |
| Macquarie | Neutral | 2026-09-04 | $200 | — | — | 0 | — |
| Evercore ISI Group | In-Line | 2026-08-27 | $210 | 2 | 0 | 2 | — |
| Canaccord Genuity | Hold | 2026-08-27 | $210 | 1 | 0 | 1 | — |
| Freedom Broker | Buy | 2026-10-14 | $320 | — | — | 0 | — |
| Bank of America | Neutral | 2026-09-18 | $260 | 1 | 0 | 1 | — |
| Stephens & Co. | Overweight | 2026-09-18 | $280 | — | — | 0 | 0 of 1 |
| Amerx | Underweight | 2026-10-08 | $212 | — | — | 0 | — |
| StoneX | Buy | 2026-10-06 | $325 | — | — | 0 | — |
| Guggenheim | Neutral | 2026-08-27 | — | — | — | 0 | — |
| HSBC | Buy | 2026-02-13 | — | — | — | 0 | — |
| Berenberg | Buy | 2026-01-09 | — | — | — | 0 | — |
| Freedom Capital Markets | Buy | 2025-12-11 | — | — | — | 0 | — |
| Goldman Sachs | Buy | 2025-12-04 | — | — | — | 0 | 1 of 1 |
Counts for one firm on one stock are small and move together; they are a record, not a grade. Neither the firms nor CRWD carry a letter here. Why →
Every call, last 12 months
| Date | Firm | Rating | Action | Price at call | Target | Target status | Move in the 30 days before |
|---|---|---|---|---|---|---|---|
| 2026-10-22 | Mizuho | Outperform | maintained | $237.94 | $275 | running to 2027-10-22 | -4.8% |
| 2026-10-16 | KeyBanc | Overweight | maintained | $227.39 | $265 | reached 2026-10-27 | -5.8% |
| 2026-10-15 | Citigroup | Buy | maintained | $244.57 | $295 | running to 2027-10-15 | +0.9% |
| 2026-10-14 | Freedom Broker | Buy | maintained | $249.29 | $320 | running to 2027-10-14 | +5.9% |
| 2026-10-14 | BTIG | Buy | maintained | $249.29 | $312 | running to 2027-10-14 | +5.9% |
| 2026-10-13 | Wells Fargo | Overweight | maintained | $261.21 | $300 | running to 2027-10-13 | +26.4% |
| 2026-10-09 | Needham | Buy | maintained | $275.04 | $310 | running to 2027-10-09 | +32.4% |
| 2026-10-08 | BMO Capital | Outperform | maintained | $263.01 | $295 | running to 2027-10-08 | +25.2% |
| 2026-10-08 | Amerx | Underweight | initiated | $263.01 | $212 | running to 2027-10-08 | +25.2% |
| 2026-10-06 | StoneX | Buy | maintained | $278.86 | $325 | running to 2027-10-06 | +30.9% |
| 2026-10-02 | TD Cowen | Buy | maintained | $270.04 | $280 | within 5% of price when set | +32.8% |
| 2026-09-21 | Morgan Stanley | Overweight | maintained | $249.35 | $254 | within 5% of price when set | +29.9% |
| 2026-09-18 | Bank of America | Neutral | maintained | $237.65 | $260 | reached 2026-09-23 | +17.9% |
| 2026-09-18 | Stephens & Co. | Overweight | maintained | $237.65 | $280 | running to 2027-09-18 | +17.9% |
| 2026-09-17 | Bernstein | Market Perform | maintained | $245.70 | $132 | running to 2027-09-17 | +15.4% |
| 2026-09-04 | Macquarie | Neutral | maintained | $213.10 | $200 | running to 2027-09-04 | +1.5% |
| 2026-09-04 | Roth Capital | Buy | maintained | $213.10 | $220 | within 5% of price when set | +1.5% |
| 2026-09-04 | Scotiabank | Sector Outperform | maintained | $213.10 | $265 | reached 2026-10-01 | +1.5% |
| 2026-09-04 | Rosenblatt | Buy | maintained | $213.10 | $250 | reached 2026-09-22 | +1.5% |
| 2026-09-03 | Raymond James | Outperform | maintained | $214.97 | $250 | reached 2026-09-22 | +1.8% |
| 2026-09-03 | TD Cowen | Buy | reiterated | $214.97 | $250 | reached 2026-09-22 | +1.8% |
| 2026-09-03 | RBC Capital | Outperform | reiterated | $214.97 | $260 | reached 2026-09-23 | +1.8% |
| 2026-09-03 | Baird | Neutral | maintained | $214.97 | $235 | reached 2026-09-14 | +1.8% |
| 2026-09-03 | Needham | Buy | reiterated | $214.97 | $250 | reached 2026-09-22 | +1.8% |
| 2026-09-03 | BTIG | Buy | reiterated | $214.97 | $245 | reached 2026-09-17 | +1.8% |
| 2026-09-02 | DA Davidson | Buy | maintained | $203.42 | $245 | reached 2026-09-17 | +0.4% |
| 2026-09-01 | Truist Securities | Buy | maintained | $215.07 | $300 | running to 2027-09-01 | +12.7% |
| 2026-08-28 | Wells Fargo | Overweight | maintained | $218.40 | $235 | reached 2026-09-14 | +21.8% |
| 2026-08-28 | Argus Research | Buy | maintained | $218.40 | $425 | running to 2027-08-28 | +21.8% |
| 2026-08-27 | Citigroup | Buy | maintained | $227.96 | $260 | reached 2026-09-23 | +25.4% |
| 2026-08-27 | Mizuho | Outperform | maintained | $227.96 | $250 | reached 2026-09-22 | +25.4% |
| 2026-08-27 | BMO Capital | Outperform | maintained | $227.96 | $235 | within 5% of price when set | +25.4% |
| 2026-08-27 | Jefferies | Buy | maintained | $227.96 | $240 | reached 2026-09-15 | +25.4% |
| 2026-08-27 | Baird | Neutral | maintained | $227.96 | $230 | within 5% of price when set | +25.4% |
| 2026-08-27 | Piper Sandler | Overweight | maintained | $227.96 | $240 | reached 2026-09-15 | +25.4% |
| 2026-08-27 | Canaccord Genuity | Hold | maintained | $227.96 | $210 | reached 2026-09-02 | +25.4% |
| 2026-08-27 | Macquarie | Neutral | maintained | $227.96 | $200 | running to 2027-08-27 | +25.4% |
| 2026-08-27 | TD Cowen | Buy | maintained | $227.96 | $250 | reached 2026-09-22 | +25.4% |
| 2026-08-27 | Bernstein | Market Perform | maintained | $227.96 | $119 | replaced 2026-09-17, new $132 | +25.4% |
| 2026-08-27 | RBC Capital | Outperform | maintained | $227.96 | $260 | reached 2026-09-23 | +25.4% |
| 2026-08-27 | UBS | Buy | maintained | $227.96 | $250 | reached 2026-09-22 | +25.4% |
| 2026-08-27 | Citizens | Market Outperform | reiterated | $227.96 | $230 | within 5% of price when set | +25.4% |
| 2026-08-27 | Rosenblatt | Buy | maintained | $227.96 | $250 | reached 2026-09-22 | +25.4% |
| 2026-08-27 | Guggenheim | Neutral | reiterated | $227.96 | — | no target | +25.4% |
| 2026-08-27 | Scotiabank | Sector Outperform | maintained | $227.96 | $250 | replaced 2026-09-04, new $265 | +25.4% |
| 2026-08-27 | Morgan Stanley | Overweight | maintained | $227.96 | $238 | within 5% of price when set | +25.4% |
| 2026-08-27 | DA Davidson | Buy | maintained | $227.96 | $245 | reached 2026-09-17 | +25.4% |
| 2026-08-27 | Benchmark | Buy | reiterated | $227.96 | $250 | reached 2026-09-22 | +25.4% |
| 2026-08-27 | KeyBanc | Overweight | maintained | $227.96 | $245 | reached 2026-09-17 | +25.4% |
| 2026-08-27 | Evercore ISI Group | In-Line | maintained | $227.96 | $210 | reached 2026-09-02 | +25.4% |
| 2026-08-27 | Needham | Buy | maintained | $227.96 | $250 | reached 2026-09-22 | +25.4% |
| 2026-08-27 | Cantor Fitzgerald | Overweight | reiterated | $227.96 | $250 | reached 2026-09-22 | +25.4% |
| 2026-08-27 | BTIG | Buy | maintained | $227.96 | $245 | reached 2026-09-17 | +25.4% |
| 2026-08-24 | Jefferies | Buy | maintained | $190.68 | $230 | replaced 2026-08-27, new $240 | +4.0% |
| 2026-08-21 | Scotiabank | Sector Outperform | maintained | $191.95 | $227 | reached 2026-08-27 | +1.9% |
| 2026-08-21 | KeyBanc | Overweight | maintained | $191.95 | $240 | replaced 2026-08-27, new $245 | +1.9% |
| 2026-08-20 | JPMorgan | Overweight | maintained | $190.34 | $235 | reached 2026-09-14 | -0.4% |
| 2026-08-20 | Evercore ISI Group | In-Line | maintained | $190.34 | $205 | reached 2026-08-27 | -0.4% |
| 2026-08-19 | Mizuho | Outperform | maintained | $201.63 | $240 | replaced 2026-08-27, new $250 | +1.6% |
| 2026-08-19 | Truist Securities | Buy | maintained | $201.63 | $245 | replaced 2026-09-01, new $300 | +1.6% |
| 2026-08-19 | Cantor Fitzgerald | Overweight | maintained | $201.63 | $250 | reached 2026-09-22 | +1.6% |
| 2026-08-18 | Barclays | Overweight | maintained | $212.92 | $235 | reached 2026-09-14 | +4.8% |
| 2026-08-18 | Benchmark | Buy | maintained | $212.92 | $250 | reached 2026-09-22 | +4.8% |
| 2026-08-17 | TD Cowen | Buy | maintained | $213.90 | $235 | replaced 2026-08-27, new $250 | +5.3% |
| 2026-08-17 | Wells Fargo | Overweight | maintained | $213.90 | $230 | replaced 2026-08-28, new $235 | +5.3% |
| 2026-08-14 | RBC Capital | Outperform | maintained | $216.95 | $256 | replaced 2026-08-27, new $260 | +4.9% |
| 2026-08-12 | Citizens | Market Outperform | maintained | $221.78 | $230 | within 5% of price when set | +18.0% |
| 2026-07-28 | Loop Capital | Buy | initiated | $181.80 | $230 | reached 2026-08-31 | +3.7% |
| 2026-07-22 | Argus Research | Buy | maintained | $188.42 | $230 | replaced 2026-08-28, new $425 | +11.6% |
| 2026-07-21 | Morgan Stanley | Overweight | maintained | $191.15 | $227 | reached 2026-08-27 | +11.6% |
| 2026-07-17 | Stifel | Buy | maintained | $203.08 | $230 | reached 2026-08-31 | +18.9% |
| 2026-07-16 | Citigroup | Buy | maintained | $203.76 | $250 | replaced 2026-08-27, new $260 | +19.9% |
| 2026-07-15 | BTIG | Buy | maintained | $206.77 | $237 | replaced 2026-08-27, new $245 | +19.4% |
| 2026-07-13 | Rosenblatt | Buy | maintained | $187.91 | $206 | reached 2026-07-14 | +10.1% |
| 2026-07-09 | Needham | Buy | maintained | $198.40 | $235 | replaced 2026-08-27, new $250 | +23.1% |
| 2026-07-08 | Benchmark | Buy | maintained | $191.12 | $230 | replaced 2026-08-18, new $250 | +16.0% |
| 2026-07-07 | Stifel | Buy | maintained | $194.62 | $220 | replaced 2026-07-17, new $230 | +16.0% |
| 2026-07-07 | Morgan Stanley | Overweight | maintained | $194.62 | $172 | replaced 2026-07-21, new $227 | +16.0% |
| 2026-07-07 | UBS | Buy | maintained | $194.62 | $235 | replaced 2026-08-27, new $250 | +16.0% |
| 2026-07-06 | Barclays | Overweight | maintained | $199.38 | $169 | replaced 2026-08-18, new $235 | +18.9% |
| 2026-07-02 | Morgan Stanley | Overweight | maintained | $193.98 | $172 | replaced 2026-07-07, new $172 | +0.9% |
| 2026-06-23 | Rosenblatt | Buy | maintained | $170.23 | — | no target | +2.6% |
| 2026-06-04 | Macquarie | Neutral | maintained | $179.77 | — | no target | +50.9% |
| 2026-06-04 | UBS | Buy | maintained | $179.77 | — | no target | +50.9% |
| 2026-06-04 | Citigroup | Buy | maintained | $179.77 | — | no target | +50.9% |
| 2026-06-04 | Bank of America | Neutral | maintained | $179.77 | — | no target | +50.9% |
| 2026-06-04 | BNP Paribas | Neutral | maintained | $179.77 | $520 | running to 2027-06-04 | +50.9% |
| 2026-06-04 | Jefferies | Buy | maintained | $179.77 | — | no target | +50.9% |
| 2026-06-04 | Canaccord Genuity | Hold | maintained | $179.77 | — | no target | +50.9% |
| 2026-06-04 | Bernstein | Market Perform | maintained | $179.77 | $413 | replaced 2026-08-27, new $119 | +50.9% |
| 2026-06-04 | Morgan Stanley | Overweight | maintained | $179.77 | — | no target | +50.9% |
| 2026-06-04 | TD Cowen | Buy | maintained | $179.77 | — | no target | +50.9% |
| 2026-06-04 | DA Davidson | Buy | maintained | $179.77 | — | no target | +50.9% |
| 2026-06-04 | Stifel | Buy | maintained | $179.77 | — | no target | +50.9% |
| 2026-06-04 | Piper Sandler | Overweight | reiterated | $179.77 | — | no target | +50.9% |
| 2026-06-04 | Truist Securities | Buy | maintained | $179.77 | — | no target | +50.9% |
| 2026-06-04 | Rosenblatt | Buy | maintained | $179.77 | — | no target | +50.9% |
| 2026-06-04 | RBC Capital | Outperform | maintained | $179.77 | — | no target | +50.9% |
| 2026-06-04 | Wells Fargo | Overweight | maintained | $179.77 | — | no target | +50.9% |
| 2026-06-04 | Wedbush | Outperform | maintained | $179.77 | — | no target | +50.9% |
| 2026-06-04 | Barclays | Overweight | maintained | $179.77 | — | no target | +50.9% |
| 2026-06-04 | Cantor Fitzgerald | Overweight | maintained | $179.77 | — | no target | +50.9% |
| 2026-06-04 | Scotiabank | Sector Outperform | maintained | $179.77 | — | no target | +50.9% |
| 2026-06-04 | Citizens | Market Outperform | maintained | $179.77 | — | no target | +50.9% |
| 2026-06-04 | Benchmark | Buy | maintained | $179.77 | — | no target | +50.9% |
| 2026-06-04 | BMO Capital | Outperform | maintained | $179.77 | — | no target | +50.9% |
| 2026-06-04 | Baird | Neutral | maintained | $179.77 | $520 | replaced 2026-08-27, new $230 | +50.9% |
| 2026-06-04 | Mizuho | Outperform | maintained | $179.77 | — | no target | +50.9% |
| 2026-06-04 | Susquehanna | Positive | maintained | $179.77 | — | no target | +50.9% |
| 2026-06-04 | Needham | Buy | maintained | $179.77 | — | no target | +50.9% |
| 2026-06-04 | BTIG | Buy | reiterated | $179.77 | — | no target | +50.9% |
| 2026-06-02 | JPMorgan | Overweight | maintained | $192.24 | — | no target | +68.8% |
| 2026-06-02 | Baird | Neutral | maintained | $192.24 | $490 | replaced 2026-06-04, new $520 | +68.8% |
| 2026-06-01 | Evercore ISI Group | In-Line | maintained | $195.54 | — | no target | +71.7% |
| 2026-05-29 | Jefferies | Buy | maintained | $182.75 | — | no target | +61.6% |
| 2026-05-27 | Benchmark | Buy | maintained | $161.34 | — | no target | +42.0% |
| 2026-05-27 | Wedbush | Outperform | maintained | $161.34 | — | no target | +42.0% |
| 2026-05-26 | BTIG | Buy | maintained | $167.89 | — | no target | +49.9% |
| 2026-05-21 | Wells Fargo | Overweight | maintained | $162.06 | — | no target | +44.2% |
| 2026-05-20 | Morgan Stanley | Overweight | maintained | $162.53 | — | no target | +50.1% |
| 2026-05-20 | Cantor Fitzgerald | Overweight | maintained | $162.53 | — | no target | +50.1% |
| 2026-05-20 | Stifel | Buy | maintained | $162.53 | — | no target | +50.1% |
| 2026-05-19 | Truist Securities | Buy | maintained | $154.22 | — | no target | +45.5% |
| 2026-05-19 | TD Cowen | Buy | maintained | $154.22 | — | no target | +45.5% |
| 2026-05-19 | Barclays | Overweight | maintained | $154.22 | — | no target | +45.5% |
| 2026-05-18 | KeyBanc | Overweight | maintained | $154.71 | — | no target | +46.0% |
| 2026-05-14 | BTIG | Buy | maintained | $144.99 | — | no target | +45.5% |
| 2026-05-05 | Wells Fargo | Overweight | maintained | $119.13 | — | no target | +19.4% |
| 2026-04-27 | Mizuho | Neutral → Outperform | upgrade | $113.65 | — | no target | +23.0% |
| 2026-04-21 | KeyBanc | Sector Weight → Overweight | upgrade | $112.40 | — | no target | +9.9% |
| 2026-03-30 | Wolfe Research | Peer Perform → Outperform | upgrade | $95.01 | — | no target | +2.2% |
| 2026-03-17 | RBC Capital | Outperform | reiterated | $108.30 | — | no target | +0.8% |
| 2026-03-10 | Morgan Stanley | Equal-Weight → Overweight | upgrade | $109.08 | — | no target | +10.3% |
| 2026-03-05 | Citigroup | Buy | maintained | $106.54 | — | no target | +1.1% |
| 2026-03-04 | DA Davidson | Buy | maintained | $101.92 | — | no target | -7.1% |
| 2026-03-04 | Macquarie | Neutral | maintained | $101.92 | — | no target | -7.1% |
| 2026-03-04 | Evercore ISI Group | In-Line | maintained | $101.92 | — | no target | -7.1% |
| 2026-03-04 | BNP Paribas | Neutral | maintained | $101.92 | — | no target | -7.1% |
| 2026-03-04 | UBS | Buy | maintained | $101.92 | — | no target | -7.1% |
| 2026-03-04 | RBC Capital | Outperform | reiterated | $101.92 | — | no target | -7.1% |
| 2026-03-04 | Rosenblatt | Buy | maintained | $101.92 | — | no target | -7.1% |
| 2026-03-04 | Canaccord Genuity | Hold | maintained | $101.92 | — | no target | -7.1% |
| 2026-03-04 | Cantor Fitzgerald | Overweight | reiterated | $101.92 | — | no target | -7.1% |
| 2026-03-04 | Bernstein | Market Perform | maintained | $101.92 | — | no target | -7.1% |
| 2026-03-04 | Morgan Stanley | Equal-Weight | maintained | $101.92 | — | no target | -7.1% |
| 2026-03-04 | BMO Capital | Outperform | maintained | $101.92 | — | no target | -7.1% |
| 2026-03-04 | Needham | Buy | maintained | $101.92 | — | no target | -7.1% |
| 2026-03-03 | Wells Fargo | Overweight | initiated | $97.86 | — | no target | -11.3% |
| 2026-03-03 | BTIG | Buy | reiterated | $97.86 | — | no target | -11.3% |
| 2026-03-02 | Baird | Neutral | maintained | $96.21 | — | no target | -12.8% |
| 2026-03-02 | Piper Sandler | Neutral → Overweight | upgrade | $96.21 | — | no target | -12.8% |
| 2026-03-02 | BTIG | Buy | maintained | $96.21 | — | no target | -12.8% |
| 2026-02-25 | Evercore ISI Group | In-Line | maintained | $90.83 | — | no target | -22.4% |
| 2026-02-24 | TD Cowen | Buy | maintained | $87.56 | — | no target | -22.6% |
| 2026-02-24 | Oppenheimer | Outperform | reiterated | $87.56 | — | no target | -22.6% |
| 2026-02-24 | Cantor Fitzgerald | Overweight | maintained | $87.56 | — | no target | -22.6% |
| 2026-02-23 | Stifel | Buy | maintained | $87.58 | — | no target | -22.6% |
| 2026-02-20 | Barclays | Overweight | maintained | $97.15 | — | no target | -12.8% |
| 2026-02-17 | Truist Securities | Buy | maintained | $103.57 | — | no target | -8.7% |
| 2026-02-17 | Mizuho | Neutral | maintained | $103.57 | — | no target | -8.7% |
| 2026-02-13 | HSBC | Hold → Buy | upgrade | $107.41 | — | no target | -6.7% |
| 2026-01-27 | Macquarie | Neutral | maintained | $119.17 | — | no target | -0.9% |
| 2026-01-13 | BTIG | Buy | reiterated | $117.00 | — | no target | -7.3% |
| 2026-01-13 | Citigroup | Buy | maintained | $117.00 | — | no target | -7.3% |
| 2026-01-12 | KeyBanc | Overweight → Sector Weight | downgrade | $116.75 | — | no target | -7.5% |
| 2026-01-09 | Berenberg | Hold → Buy | upgrade | $117.65 | — | no target | -9.4% |
| 2025-12-18 | Morgan Stanley | Equal-Weight | maintained | $119.32 | — | no target | -7.1% |
| 2025-12-18 | Stephens & Co. | Overweight | reiterated | $119.32 | — | no target | -7.1% |
| 2025-12-11 | Freedom Capital Markets | Hold → Buy | upgrade | $129.41 | — | no target | -7.0% |
| 2025-12-11 | Freedom Broker | Hold → Buy | upgrade | $129.41 | — | no target | -7.0% |
| 2025-12-04 | Citigroup | Buy | maintained | $128.28 | — | no target | -3.9% |
| 2025-12-04 | Goldman Sachs | Buy | maintained | $128.28 | — | no target | -3.9% |
| 2025-12-03 | Macquarie | Neutral | maintained | $131.04 | — | no target | -5.0% |
| 2025-12-03 | DA Davidson | Buy | maintained | $131.04 | — | no target | -5.0% |
| 2025-12-03 | Piper Sandler | Neutral | maintained | $131.04 | — | no target | -5.0% |
| 2025-12-03 | RBC Capital | Outperform | reiterated | $131.04 | — | no target | -5.0% |
| 2025-12-03 | Wedbush | Outperform | reiterated | $131.04 | — | no target | -5.0% |
| 2025-12-03 | Evercore ISI Group | In-Line | maintained | $131.04 | — | no target | -5.0% |
| 2025-12-03 | Cantor Fitzgerald | Overweight | reiterated | $131.04 | — | no target | -5.0% |
| 2025-12-03 | Susquehanna | Positive | maintained | $131.04 | — | no target | -5.0% |
| 2025-12-03 | Citizens | Market Outperform | reiterated | $131.04 | — | no target | -5.0% |
| 2025-12-03 | UBS | Buy | maintained | $131.04 | — | no target | -5.0% |
| 2025-12-03 | Canaccord Genuity | Hold | maintained | $131.04 | — | no target | -5.0% |
| 2025-12-03 | Scotiabank | Sector Outperform | maintained | $131.04 | — | no target | -5.0% |
| 2025-12-03 | BMO Capital | Outperform | maintained | $131.04 | — | no target | -5.0% |
| 2025-12-03 | Rosenblatt | Buy | maintained | $131.04 | — | no target | -5.0% |
| 2025-12-03 | JPMorgan | Overweight | maintained | $131.04 | — | no target | -5.0% |
| 2025-12-03 | BTIG | Buy | reiterated | $131.04 | — | no target | -5.0% |
| 2025-12-03 | Needham | Buy | maintained | $131.04 | — | no target | -5.0% |
| 2025-12-01 | Wedbush | Outperform | reiterated | $126.03 | — | no target | -7.2% |
| 2025-12-01 | JPMorgan | Overweight | maintained | $126.03 | — | no target | -7.2% |
| 2025-12-01 | KeyBanc | Overweight | maintained | $126.03 | — | no target | -7.2% |
| 2025-11-25 | DA Davidson | Buy | maintained | $128.09 | — | no target | — |
| 2025-11-21 | Oppenheimer | Outperform | maintained | $122.67 | — | no target | — |
| 2025-11-18 | Truist Securities | Buy | maintained | $128.42 | — | no target | — |
| 2025-11-18 | Rosenblatt | Buy | maintained | $128.42 | — | no target | — |
| 2025-11-17 | Mizuho | Neutral | maintained | $132.45 | — | no target | — |
| 2025-11-17 | Stifel | Buy | maintained | $132.45 | — | no target | — |
| 2025-11-14 | Baird | Neutral | maintained | $134.39 | — | no target | — |
| 2025-11-14 | Barclays | Overweight | maintained | $134.39 | — | no target | — |
| 2025-11-13 | Morgan Stanley | Equal-Weight | maintained | $132.45 | — | no target | — |
| 2025-11-04 | BTIG | Buy | maintained | $133.48 | — | no target | — |
Also in Cybersecurity
Interactive version with the price chart and target overlay: Scorecard tab on the dashboard. All covered names: index.
How calls are checked
Every call is checked on the firm's own terms. A price target is followed until its own deadline (12 months unless the firm publishes a different horizon) and ends as reached (the stock closed at or beyond it while it stood), replaced (the same firm set a new target first) or short at deadline. A rating is compared with the stock's sector SPDR ETF on total return over the rating's life, because most big-firm ratings are relative: Overweight means "beat its peers", not "go up". Hold-type ratings are tracked, not graded. A firm is numbered only with 30+ resolved targets, and a letter prints only for a firm's whole record where an exact test separates it from a coin flip. None of this is a verdict on anyone's skill, and one day is never a grade. The full method →
Get the daily brief
Our take, the S&P 500 Pulse, the Street's calls and today's docket — one email, weekdays, 9 AM ET, 30 minutes before the open.